| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9153769 | American Heart Journal | 2005 | 6 Pages |
Abstract
Long-term bosentan treatment in adult patients with PAH-CHD was well tolerated and improved functional status as well as exercise capacity. These findings have to be corroborated by controlled studies that are presently ongoing.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ingram Schulze-Neick, Nadine Gilbert, Ralf Ewert, Christian Witt, Ekkehard Gruenig, Beate Enke, Mathias M. Borst, Peter E. Lange, Marius M. Hoeper,